Cargando…

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?

Research-based immunotherapy trials seeking to prevent or reverse a number of autoimmune diseases, including type 1 diabetes, have seen near universal suspension due to the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haller, Michael J., Jacobsen, Laura M., Posgai, Amanda L., Schatz, Desmond A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173800/ https://www.ncbi.nlm.nih.gov/pubmed/33632743 http://dx.doi.org/10.2337/dbi20-0045

Ejemplares similares

Tackling Loneliness and Isolation in Older Adults With Virtual Reality: How do We Move Forward?
por: Finnegan, Daniel J., et al.
Publicado: (2023)

Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2012)

Current Challenges Facing Women in Gastroenterology: How Do We Move Forward?
por: Shukla, Richa
Publicado: (2016)

Moving toward multimedia electronic health records: how do we get there?
por: Seto, Belinda, et al.
Publicado: (2012)

How Do We Move Forward With Trauma-Informed Care?
por: Schimmels, JoEllen, et al.
Publicado: (2021)

Clinical Islet Xenotransplantation: How Close Are We?
por: van der Windt, Dirk J., et al.
Publicado: (2012)

Cancer in Croatia; where do we stand and how to move forward?
por: Vrdoljak, Eduard
Publicado: (2012)

COVID-19; beyond the obvious: how do we move forward?
por: Nasoodi, Afshin, et al.
Publicado: (2020)

Malaria: How Are We Doing and How Can We Do Better?
por: Rosenthal, Philip J., et al.
Publicado: (2019)

Management of Cryptococcosis: How Are We Doing?
por: Perfect, John R
Publicado: (2007)

Metabolomics Applied to Diabetes Research: Moving From Information to Knowledge
por: Bain, James R., et al.
Publicado: (2009)

On the use of simulation in robotics: Opportunities, challenges, and suggestions for moving forward
por: Choi, HeeSun, et al.
Publicado: (2021)

How Do We “Validate” a QSP Model?
por: Kirouac, Daniel C.
Publicado: (2018)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

In medicine, how do we machine learn anything real?
por: Ghassemi, Marzyeh, et al.
Publicado: (2022)

How Do We Explore Heterogeneity in Turnover of Musculoskeletal Proteins?
por: Agergaard, Jakob, et al.
Publicado: (2021)

How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?
por: Tesfaye, Wubshet, et al.
Publicado: (2020)

COVID toes: where do we stand with the current evidence?
por: Baeck, Marie, et al.
Publicado: (2021)

Nutrition Therapy in Gestational Diabetes Mellitus: Time to Move Forward
por: Hernandez, Teri L., et al.
Publicado: (2018)

PANDEMIC POLICIES MOVING FORWARD: WHAT HAVE WE LEARNED
por: Lindberg, Brian
Publicado: (2022)

Public Data Archiving in Ecology and Evolution: How Well Are We Doing?
por: Roche, Dominique G., et al.
Publicado: (2015)

Modern Compact Cities: How Much Greenery Do We Need?
por: Russo, Alessio, et al.
Publicado: (2018)

How do we teach surgical residents in the COVID-19 era?
por: Okland, Tyler S., et al.
Publicado: (2020)

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
por: Skyler, Jay S., et al.
Publicado: (2017)

Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
por: Staeva, Teodora P., et al.
Publicado: (2013)

T Cell Receptor Profiling in Type 1 Diabetes
por: Jacobsen, Laura M., et al.
Publicado: (2017)

Developmental Programming of Obesity and Diabetes in Mouse, Monkey, and Man in 2018: Where Are We Headed?
por: Friedman, Jacob E.
Publicado: (2018)

Burkholderia vaccines: are we moving forward?
por: Choh, Leang-Chung, et al.
Publicado: (2013)

Current Advances and Travails in Islet Transplantation
por: Harlan, David M., et al.
Publicado: (2009)

Metformin Pharmacogenomics: Current Status and Future Directions
por: Pawlyk, Aaron C., et al.
Publicado: (2014)

Insulin Regulates Brain Function, but How Does It Get There?
por: Gray, Sarah M., et al.
Publicado: (2014)

Universal health coverage in Iran: Where we stand and how we can move forward
por: Sajadi, Haniye Sadat, et al.
Publicado: (2019)

Emerging Pandemic Diseases: How We Got to COVID-19
por: Morens, David M., et al.
Publicado: (2020)

EP37 A need to train paediatric rheumatologists in musculoskeletal ultrasound scanning. How do we move forward?
por: Jenabi, Fatemeh, et al.
Publicado: (2020)

Food-Based Dietary Guidelines and Protein Quality Definitions—Time to Move Forward and Encompass Mycoprotein?
por: Derbyshire, Emma
Publicado: (2022)

Smart wearable devices in cardiovascular care: where we are and how to move forward
por: Bayoumy, Karim, et al.
Publicado: (2021)

Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?
por: Dowdy, Steven F.
Publicado: (2023)

Genome-forward oncology: how do we get there?
por: Ellis, Matthew
Publicado: (2011)

The Theory Crisis in Psychology: How to Move Forward
por: Eronen, Markus I., et al.
Publicado: (2021)

Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans?
por: Liu, Jiwen (Jim), et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_otnri7vn5fnihr9fd6o0sc8p77